Advertisement

Treatment and survival among 1594 patients with ATL

Hiroo Katsuya, Kenji Ishitsuka, Atae Utsunomiya, Shuichi Hanada, Tetsuya Eto, Yukiyoshi Moriuchi, Yoshio Saburi, Masaharu Miyahara, Eisaburo Sueoka, Naokuni Uike, Shinichiro Yoshida, Kiyoshi Yamashita, Kunihiro Tsukasaki, Hitoshi Suzushima, Yuju Ohno, Hitoshi Matsuoka, Tatsuro Jo, Masahiro Amano, Ryosuke Hino, Mototsugu Shimokawa, Kazuhiro Kawai, Junji Suzumiya and Kazuo Tamura on behalf of the ATL–Prognostic Index Project

Article Information

Citation 
vol. 126 no. 24 2570-2577
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted March 4, 2015
  • Accepted August 24, 2015
  • Published online December 3, 2015.


Contributors 
  • Hiroo Katsuya, 1Division of Medical Oncology, Hematology and Infectious Diseases, Department of Medicine, School of Medicine, Fukuoka University, Fukuoka, Japan;
  • Kenji Ishitsuka, 1Division of Medical Oncology, Hematology and Infectious Diseases, Department of Medicine, School of Medicine, Fukuoka University, Fukuoka, Japan;
  • Atae Utsunomiya, 2Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan;
  • Shuichi Hanada, 3Department of Hematology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan;
  • Tetsuya Eto, 4Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan;
  • Yukiyoshi Moriuchi, 5Department of Hematology, Sasebo City General Hospital, Sasebo, Japan;
  • Yoshio Saburi, 6Department of Hematology, Oita Prefectural Hospital, Oita, Japan;
  • Masaharu Miyahara, 7Department of Internal Medicine, Karatsu Red Cross Hospital, Karatsu, Japan;
  • Eisaburo Sueoka, 8Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan;
  • Naokuni Uike, 9Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan;
  • Shinichiro Yoshida, 10Department of Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan;
  • Kiyoshi Yamashita, 11Department of Internal Medicine, Miyazaki Prefectural Hospital, Miyazaki, Japan;
  • Kunihiro Tsukasaki, 12Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan;
  • Hitoshi Suzushima, 13Department of Hematology, Kumamoto Shinto General Hospital, Kumamoto, Japan;
  • Yuju Ohno, 14Department of Internal Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan;
  • Hitoshi Matsuoka, 15Department of Internal Medicine, Koga General Hospital, Miyazaki, Japan;
  • Tatsuro Jo, 16Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan;
  • Masahiro Amano, 17Department of Dermatology, Miyazaki University, Miyazaki, Japan;
  • Ryosuke Hino, 18Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan;
  • Mototsugu Shimokawa, 19Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan;
  • Kazuhiro Kawai, 20Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan; and
  • Junji Suzumiya, 21Cancer Center, Shimane University Hospital, Izumo, Japan
  • Kazuo Tamura, 1Division of Medical Oncology, Hematology and Infectious Diseases, Department of Medicine, School of Medicine, Fukuoka University, Fukuoka, Japan;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output